Resources Management Corp’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-175
Closed -$35K 209
2026
Q1
$35K Hold
175
﹤0.01% 276
2025
Q4
$32K Hold
175
﹤0.01% 289
2025
Q3
$27K Hold
175
﹤0.01% 286
2025
Q2
$24K Hold
175
﹤0.01% 307
2025
Q1
$26K Hold
175
﹤0.01% 312
2024
Q4
$23K Hold
175
﹤0.01% 320
2024
Q3
$27K Hold
175
﹤0.01% 321
2024
Q2
$27K Hold
175
﹤0.01% 315
2024
Q1
$24K Hold
175
﹤0.01% 326
2023
Q4
$24K Hold
175
﹤0.01% 324
2023
Q3
$24K Hold
175
﹤0.01% 318
2023
Q2
$25K Buy
175
+30
+21% +$4.41K ﹤0.01% 321
2023
Q1
$23K Sell
145
-105
-42% -$14.1K ﹤0.01% 320
2022
Q4
$34K Hold
250
0.01% 318
2022
Q3
$27K Hold
250
﹤0.01% 334
2022
Q2
$33K Hold
250
0.01% 331
2022
Q1
$33K Sell
250
-50
-17% -$6K ﹤0.01% 336
2021
Q4
$35K Hold
300
﹤0.01% 349
2021
Q3
$36K Hold
300
0.01% 337
2021
Q2
$36K Hold
300
0.01% 350
2021
Q1
$30K Hold
300
﹤0.01% 344
2020
Q4
$30K Sell
300
-250
-45% -$26.5K ﹤0.01% 340
2020
Q3
$60K Hold
550
0.01% 280
2020
Q2
$58K Hold
550
0.01% 286
2020
Q1
$49K Hold
550
0.01% 289
2019
Q4
$55K Hold
550
0.01% 290
2019
Q3
$49K Buy
+550
New +$47.7K 0.01% 302
2018
Q4
$41K Hold
550
0.01% 295
2018
Q3
$43K Buy
+550
New +$41.6K 0.01% 297

Other funds holding AZN

Resources Management Corp's AZN Position: Q2 2026 in Review

Resources Management Corp sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 175 shares — an estimated $35K sold.

Resources Management Corp first reported a position in AZN in Q3 2018 and held it in 29 quarters. The position peaked at $60K in Q3 2020. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Resources Management Corp reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • Resources Management Corp sold 175 AstraZeneca shares in Q2 2026, an estimated $35K.
  • Resources Management Corp first reported a position in AstraZeneca in Q3 2018 and held it in 29 quarters.
  • Resources Management Corp's AstraZeneca position peaked at $60K in Q3 2020.
  • 1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Resources Management Corp's 13F filing for Q2 2026, filed 14 Aug 2026.